Epidemiology of HER2-low breast cancer in Lithuania

被引：0
|
作者：
Cesas, A. [1 ]
Poskiene, L. [2 ]
Valkiuniene, R. B. [3 ]
Radvinskiene, L. [4 ]
Lege, I. [5 ]
机构：
[1] Klaipeda Univ Hosp, Dept Oncol, Klaipeda, Lithuania
[2] Lithuanian Univ Hlth Sci, Dept Pathol, Kaunas, Lithuania
[3] Natl Ctr Pathol, Dept Breast Pathol, Vilnius, Lithuania
[4] Klaipeda Univ Hosp, Dept Pathol, Klaipeda, Lithuania
[5] AstraZeneca, Balt Med & Regulatory Dept, Vilnius, Lithuania
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 200卷
关键词：
D O I：
10.1016/j.ejca.2024.113843
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
276 (PB-09
引用
收藏
页码：103 / 104
页数：2
相关论文
共 50 条
  • [1] Trastuzumab Deruxtecan in HER2-Low Breast Cancer
    Carroll, Hailey K.
    Higgins, Michaela J.
    O'Reilly, Seamus
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (12): : 1144 - 1144
  • [2] Biology and Treatment of HER2-Low Breast Cancer
    Nicolo, Eleonora
    Tarantino, Paolo
    Curigliano, Giuseppe
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (01) : 117 - 132
  • [3] Clinical Significance of HER2-low Breast Cancer
    Zaiem, Fadi
    AbuJamea, Asem
    Kheil, Mira
    Numi, Anna
    Abbas, Omar
    Awada, Sanaa
    Almsaddi, Ragad
    Al-Juburi, Saleh
    Larson, Lauren
    Jain, Deepti
    AlSaghir, Maya
    Jang, Hyejeong
    Kim, Seongho
    Bandyopadhyay, Sudeshna
    Jaiman, Sunil
    Ali-Fehmi, Rouba
    CANCER RESEARCH, 2024, 84 (09)
  • [4] HER2-Low Breast Cancer: a New Subtype?
    Chiara Corti
    Federica Giugliano
    Eleonora Nicolò
    Paolo Tarantino
    Carmen Criscitiello
    Giuseppe Curigliano
    Current Treatment Options in Oncology, 2023, 24 : 468 - 478
  • [5] HER2-low breast cancer: where are we?
    Molinelli, Chiara
    Jacobs, Flavia
    Marchio, Caterina
    Pitto, Francesca
    Cosso, Maurizio
    Spinaci, Stefano
    de Azambuja, Evandro
    Schettini, Francesco
    Agostinetto, Elisa
    Lambertini, Matteo
    BREAST CARE, 2022, 17 (06) : 533 - 544
  • [6] HER2-Low Breast Cancer: a New Subtype?
    Corti, Chiara
    Giugliano, Federica
    Nicolo, Eleonora
    Tarantino, Paolo
    Criscitiello, Carmen
    Curigliano, Giuseppe
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (05) : 468 - 478
  • [7] HER2-Low Breast Cancer: Now and in the Future
    Kang, Sora
    Kim, Sung-Bae
    CANCER RESEARCH AND TREATMENT, 2024, 56 (03): : 700 - 720
  • [8] Epidemiology and Prognosis of HER2-Low Breast Cancer (BC) in the National Cancer Data Base (NCDB)
    Peiffer, Daniel
    Howard, Frederick M.
    Chen, Nan
    Hahn, Olwen M.
    Nanda, Rita
    Olopade, Olufunmilayo I.
    Huo, Dezheng
    CANCER RESEARCH, 2023, 83 (05)
  • [9] HER2-Low expression in primary male breast cancer
    Rudlowski, Christian
    Erices-Leclercq, Melanie
    Nobbe, Katleen
    Baldus, Stephan
    Foerster, Robert
    Foerster, Frank
    Lubig, Sabine
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 29 - 29
  • [10] Genomic and Transcriptomic Landscape of HER2-Low Breast Cancer
    Bansal, Rani
    McGrath, Julie
    Walker, Phil
    Bustos, Matias A.
    Rodriguez, Estelamari
    Sammons, Sarah L.
    Accordino, Melissa K.
    Meisel, Jane
    Gatti-Mays, Margaret
    Hsu, Emily
    Lathrop, Kate I.
    Kaklamani, Virginia
    Oberley, Matthew
    Korn, W. Michael
    Graff, Stephanie L.
    CANCER RESEARCH, 2023, 83 (05)
12345